Clinical

Dataset Information

0

Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFR


ABSTRACT: patients with metastatic colorectal cancer who were initially RAS wild and failed at least 2 lines of chemotherapy will be enrolled. Anti-EGFR must have been given in 1st line. Those who remain RAS-wild upon retesting will receive rechallenge with panitumumab and chemotherapy

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2304800 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2326638 | ecrin-mdr-crc
| 2348546 | ecrin-mdr-crc
| 2651470 | ecrin-mdr-crc
2022-03-28 | GSE194058 | GEO
| 2250118 | ecrin-mdr-crc
| 2256554 | ecrin-mdr-crc
2020-12-07 | MSV000086569 | MassIVE
| phs001072 | dbGaP
2020-05-27 | PXD014755 | Pride
2010-03-01 | GSE15326 | GEO